Takarazuka City Hospital

Recent papers from Takarazuka City Hospital

1. A Rare Case of Impacted Mandibular Central Incisor With Hyperplastic Dental FollicleOral Science International · 2026
2. Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over timeFuture Oncology · 2026
3. Association between weekend and out-of-hours emergency abdominal surgery and clinical outcomes: an exploratory retrospective cohort studyBMC Surgery · 2026
4. A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common EGFR mutation-positive NSCLCTherapeutic Advances in Medical Oncology · 2026
5. Rare delayed thromboembolic complication 18 days after Woven EndoBridge implantation: A case reportSurgical Neurology International · 2026
6. Case of implant failure following osteosynthesis for an intertrochanteric femoral fracture using a carbon fiber intramedullary nailJournal of Surgical Case Reports · 2026
7. Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis CHepatology Research · 2026
8. VAF–tumor content graph: a simple visual framework for interpreting hereditary cancer variants and supporting genetic counseling in tumor-only sequencingJournal of Human Genetics · 2026
9. Long-term Outcomes of OGSG1108: A Supplemental Study of Oral Nutritional Supplementation During Adjuvant S-1 ChemotherapyAnticancer Research · 2026
10. Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomesJapanese Journal of Clinical Oncology · 2026
11. Baseline DCP May Modify Response to Atezolizumab‐Bevacizumab Versus Durvalumab‐Tremelimumab in Unresectable HCCLiver International · 2026
12. Simplified BALAD (BALAD‐S) Score as a Guide for First‐Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular CarcinomaHepatology Research · 2026
13. Pressure-volume curve–derived recruitability indices are protocol-dependent in lavage-induced lung injuryRespiratory Care Reports · 2026
14. Hepatologist‐Driven Screening for Obstructive Sleep Apnea in Patients With MASLD Using a Modified STOP‐Bang Questionnaire: The SOMA ModelHepatology Research · 2026
15. Impact of Absolute PSA Value and Relative PSA Response Rate on Overall Survival in Patients With Metastatic Castration‐Sensitive Prostate Cancer Treated With Androgen Receptor Signaling InhibitorsInternational Journal of Urology · 2026
16. Rheumatologists’ Perceptions of Nurse-led Telephone Consultations for Patients with Rheumatoid Arthritis in JapanModern Rheumatology · 2026
17. Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapyHepatology Communications · 2026
18. Prevalence of MSI ‐H/ dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka‐Colorectal RegistryAnnals of Gastroenterological Surgery · 2026
19. Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real‐World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA TrialJournal of Gastroenterology and Hepatology · 2026
20. Concurrent Immune-Related Polyarthritis and Hyperbilirubinemia during Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carcinoma: A Steroid-Responsive CaseKanzo · 2026